Provided by Tiger Trade Technology Pte. Ltd.

Revelation Biosciences, Inc.

1.10
+0.01000.92%
Post-market: 1.100.00000.00%19:28 EDT
Volume:49.71K
Turnover:54.36K
Market Cap:4.38M
PE:-0.09
High:1.12
Open:1.10
Low:1.06
Close:1.09
52wk High:11.60
52wk Low:0.8750
Shares:3.98M
Float Shares:2.95M
Volume Ratio:0.73
T/O Rate:1.69%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-12.2877
EPS(LYR):-23.9458
ROE:-154.77%
ROA:-78.73%
PB:0.44
PE(LYR):-0.05

Loading ...

Revelation Biosciences Grants CEO, CFO Restricted Stock Awards of 208,076 Shares Each Under 2021 Equity Plan

Reuters
·
Aug 20

Revelation Biosciences Names Avance Clinical as CRO for Phase 2/3 Gemini AKI Trial

Reuters
·
Aug 19

Revelation Biosciences Selects Avance Clinical as Cro for Phase 2/3 Titan Study

THOMSON REUTERS
·
Aug 19

Revelation Biosciences (REVB) Gets a Buy from Roth MKM

TIPRANKS
·
Aug 08

Revelation Biosciences Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 07

Revelation Biosciences Q2 EPS $(0.87) Beats $(0.88) Estimate

Benzinga Earnings
·
Aug 07

Revelation Biosciences Q2 FY26 Net Loss Widens 35.97% to $3.32 Million

Reuters
·
Aug 07

Revelation Biosciences Inc Q2 EPS USD -0.87

Reuters
·
Aug 07

Revelation Biosciences Inc Q2 Net Income USD -3.3 Million

THOMSON REUTERS
·
Aug 07

Revelation Biosciences Inc Expected to Post a Loss of 83 Cents a Share - Earnings Preview

Reuters
·
Aug 04

Revelation Biosciences Issues 108,000 RSU Inducement Grants to New Hires

Reuters
·
Jul 22

Revelation Biosciences Issues Stockholder Rights Dividend Under New Poison Pill Plan

Reuters
·
Jul 11

Revelation Biosciences Shareholders Approved Board Authority for Reverse Stock Split Range up to 1-for-250

Reuters
·
Jun 25

Revelation Biosciences adds two new members to AKI Advisory Board

TIPRANKS
·
Jun 01

Analysts Offer Insights on Healthcare Companies: Opus Genetics (IRD), Enovis (ENOV) and Revelation Biosciences (REVB)

TIPRANKS
·
May 09

Revelation Biosciences Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 08

Revelation Biosciences Q1 EPS $(2.71) Misses $(1.55) Estimate

Benzinga Earnings
·
May 08

Revelation Biosciences Q1 2026 net loss widens to $3.01 million

Reuters
·
May 08

BRIEF-Revelation Biosciences Inc Q1 EPS USD -2.71

Reuters
·
May 08

Revelation Biosciences Inc expected to post a loss of $1.15 a share - Earnings Preview

Reuters
·
May 05